What Is... Pseudotumor Cerebri?
Simply speaking, Pseudotumor Cerebri is a condition in which the body either produces too much cerebrospinal fluid pressure or doesn't absorb it well, resulting in increased cerebrospinal fluid pressure. This condition can be related to headaches and Migraines.
Pseudotumor cerebri literally means "false brain tumor" because it's symptoms mimic those of brain tumors. It is also (more accurately) called Idiopathic Intracranial Hypertension (IIH). The term idiopathic is applied because it's cause is not truly known. Feature article.








The statistics are shocking. Nearly 50 million Americans suffer from persistent pain. Nearly 36 million are affected by Migraine disease. At least 80% of the world's population will be affected by tension-type headaches at some time in their lives. These “invisible” illnesses can be disabling and can make those afflicted by them feel isolated, alone, and powerless.
It's nothing new. Drugs that are abused or misused by a small segment of society become stigmatized. Other segments of society overreact, and the potential benefits of the drugs become lost in the shuffle.
or,
We've all heard a lot about Botox, botulinum toxin type A (BoNTA). It seems as if it's being used for something different every day. There are both cosmetic and medical applications for it. In the right hands, Botox is very helpful; in the wrong hands, it can be disastrous. If you're considering Botox treatments, don't hesitate to ask how much experience your doctor has with Botox administration.
Another medication can now be added to the growing list of medications shown to be effective for prevention of headaches and Migraine attacks. Namenda (memantine HCL, Forest Pharmaceuticals) was approved for use in the United States in October, 2003, more than a decade after its use began in Europe under the brand names Ebixa and Axura. It's classified as an orally active NMDA receptor antagonist. Namenda (memantine hydrochloride) is approved for the treatment of "moderate to severe dementia of the Alzheimer's type."




